Patent ID: 11911513
Assignee: SHANGHAI WD PHARMACEUTICAL CO., LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 9:
10. The method of claim 6, wherein in the extended release platform, when the overcoat is composed of levodopa, carbidopa, hydroxypropyl cellulose, aspartame and mint flavor, the weight percentage of the levodopa is 23.78%, the weight percentage of the carbidopa is 64.22%, the weight percentage of the hydroxypropyl cellulose is 10%, and the weight percentage of the aspartame is 1%, the weight percentage of the mint flavor is 1%; or the weight percentage of the levodopa is 54%, the weight percentage of the carbidopa is 35%, the weight percentage of the hydroxypropyl cellulose is 10%, and the weight percentage of the aspartame is 0.9%, the weight percentage of the mint flavor is 0.1%; or the weight percentage of the levodopa is 42.8%, the weight percentage of the carbidopa is 46.2%, the weight percentage of the hydroxypropyl cellulose is 10%, and the weight percentage of the aspartame is 0.9%, and the weight percentage of the mint flavor is 0.1%, wherein the weight percentage is the weight percentage of each component of the overcoat;
when the overcoat is composed of levodopa, carbidopa, hydroxypropyl cellulose, aspartame and mint flavor, the weight percentage of the levodopa is 62.15%, the weight percentage of the carbidopa is 26.85%, the weight percentage of the hydroxypropyl cellulose is 10%, the weight percentage of the aspartame is 0.9%, and the weight percentage of the mint flavor is 0.1%;
or, the weight percentage of the levodopa is 42.8%, the weight percentage of the carbidopa is 46.2%, the weight percentage of the hydroxypropyl cellulose is 10%, the weight percentage of the aspartame is 0.9%, the weight percentage of the mint flavor is 0.1%, or the weight percentage of the levodopa is 28.2%, and the weight percentage of the carbidopa is 60.8%, the weight percentage of the hydroxypropyl cellulose is 10%, the weight percentage of the aspartame is 0.9%, and the weight percentage of the mint flavor is 0.1%, wherein the weight percentage is the weight percentage of each component of the overcoat;
or, when the overcoat is composed of carbidopa, hydroxypropyl cellulose and aspartame, the weight percentage of carbidopa is 93%, the weight percentage of hydroxypropyl cellulose is 2% and the weight percentage of aspartame is 5%, wherein the weight percentage is the weight percentage of each component of the overcoat;
or, when the overcoat is composed of levodopa, hydroxypropyl cellulose and mint flavor, the weight percentage of the levodopa is 75%, the weight percentage of the hydroxypropyl cellulose is 20%, and the weight percentage of the mint flavor is 5%, wherein the weight percentage is the weight percentage of each component of the overcoat;
or, when the overcoat is composed of levodopa, carbidopa, hydroxypropyl cellulose and aspartame, the weight percentage of levodopa is 24%, the weight percentage of carbidopa is 65%, the weight percentage of hydroxypropyl cellulose is 10% and the weight percentage of aspartame is 1%, wherein the weight percentage is the weight percentage of each component of the overcoat;
or, the weight gain of the overcoat relative to the tablet core is 12.9% or 13.2% or 15.7% or 21.0% by weight.